Articles by Darrell R. Abernethy - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Darrell R. Abernethy

Inside USP: Heparin Monographs Further Revised

USP's Stage 2 heparin monograph revisions address identification, potency, and impurities.
Mar 2, 2009

USP's Stage 2 heparin monograph revisions address identification, potency, and impurities.

Inside USP: USP Metals Testing: A Workshop Report

Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.
Nov 2, 2008

Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.

Inside USP: Metrology and USP Dissolution

The United States Pharmacopeia emphasizes mechanical calibration and a performance test to esnure integrity of the dissolution procedure.
Mar 2, 2008

The United States Pharmacopeia emphasizes mechanical calibration and a performance test to esnure integrity of the dissolution procedure.

Inside USP: Annual Scientific Meeting Recap

Representatives from 17 nations sit down to decide upon standards-setting initiatives.
Nov 2, 2007

Representatives from 17 nations sit down to decide upon standards-setting initiatives.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here